Percutaneous core needle biopsy of neuroblastoma in the pediatric population: what have we learned in the last decade
Topic overview
This retrospective study of 79 pediatric neuroblastoma patients demonstrates that image-guided core needle biopsy achieves 91% diagnostic adequacy with a safety profile comparable to surgical open biopsy. The findings support CNB as the preferred first-line approach for tissue diagnosis in neuroblastoma when technically feasible.
Key takeaways
- Core needle biopsy achieved 91% adequacy rate for neuroblastoma diagnosis, comparable to surgical biopsy with similar safety profile
- CNB should be considered first-line for neuroblastoma tissue diagnosis when feasible, replacing traditional open surgical biopsy
- Image-guided CNB provides sufficient tissue for histopathological analysis while avoiding surgical morbidity in pediatric patients
- Only 3 of 35 patients required repeat biopsy after initial CNB, demonstrating high first-pass success rate
- Ten-year retrospective data supports CNB as safe alternative across all tumor stages and locations in pediatric neuroblastoma
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Percutaneous core needle biopsy of neuroblastoma in the pediatric population: what have we learned in the last decade. GlobalCastMD Medical Library. 2024-04-06. https://dev.library.globalcastmd.com/article/8481?via_space=staycurrentmd
Comments